SlideShare a Scribd company logo
1 of 34
Clinical Pharmacokinetics-1



     Prof. Dr. Talat Ahmed
THEORIES OF DRUG DISTRIBUTION AND
           ELIMINATION
THEORIES OF DRUG DISTRIBUTION
       AND ELIMINATION
1. Single compartment       a)        b)
   theory.                  central   peripheral
2. Two compartment          blood     muscle
   theory
                            CSF       skin
3. Multiple
                            lung      fat
   compartment
                            liver     bones
   theory.
                            Kidney

F, AUC, CL, Vd, t12, Css
BIOAVAILABILITY
Bioavailability (F) is the fraction of
  unchanged drug reaching the systemic
  circulation.

I/V administration = 1F (100% bioavailability)

 AUC= area under curve:
  It is a measure of the extent of bioavailability
  given by a particular route.

 F= AUC after IM or oral dose
         AUC after I/V dose
F= AUCoral/AUC i/v
FACTORS AFFECYING
       BIOAVAILABILITY

1. EXTENT OF ABSORPTION (= f)
2. RATE OF ABSORPTION
3. FIRST PASS ELIMINATION
Factors Affecting Bioavailability
1. EXTENT OF ABSORPTION (= f) :

Bioavailability is the function of absorption=f
  digoxin,       70%        intestinal microflora
  atenolol,      56%        too hydrophilic
  acyclovir      23%        too lipophilic


Grape fruit juice:↑ drug absorption
1)P-glycoprotein inhibition 2)↓wall metabolism
2. RATE OF ABSORPTION:
   it affects rate of availability,
     determined by:

a) Drug formulation
b) Amount of given drug.
c) Site of Administration.
a) Drug formulation
a) Drug formulation
• Disintegration & dissolution time Depends:
1.Compression pressure
2.Moisture Content
3.Nature of additives: excipients - starch,
  lubricants, disintegrents
4.Particle size
5.Polymorphism of molecule or ions
6.pH
Bioequivalence
Pharmaceutical Equivalent/Generic
1. Same active ingredient
2. Same strength /concentration
3. Same Dosage Form
4. Same route of Admn.

Bioequivalent
When rate & extent of bioavailability of active ingredient
    in two products is similar.
Therapeutic Equivalence
When two products produce same response in same
    dosage (e.g. aconitine hazard)
b) Amount of given drug
• FIRST ORDER ABSORPTION:
  rate of absorption is proportional to the amount
  of drug in gut.

• ZERO ORDER ABSORPTION:
  when rate of absorption is not proportionate to
  the amount of drug in the gut.
  (when full dose is not absorbed from GI fluids)
c)Site of Administration
           Oral
           Topical
        Transdermal
       Intramuscular
      Subcutaneous
        Sublingual
           Rectal
         Inhalation
3. FIRST PASS ELIMINATION:
         orally administered drug
                    ↓
               gut wall
                    ↓
               portal blood
                    ↓
                    liver

            bile       systemic circulation
The First Pass Effect and
       Extraction Ratio
Effect of first pass elimination on
      bioavailability is expressed as
     extraction ratio = ER
If a drug is completely absorbed from the gut
      its systemic bioavailability
       F = l (100 %)
If it passes through liver, it will be decreased
      by hepatic extraction
       F = l – ER
Extent Of Absorption = f
 (predicts systemic bioavailability of drug)

     F = f x (1- ER)

   For morphine f =1
               ER = 0.67
   F = 1 x (1- 0.67) = 33%
    ( observed value 24%)
Highly Extracted Drugs
Therapeutic blood concentration can be
 reached by high oral dose

 Lidocaine 20 %
 Verapamil 20%
 Propranolol 26%


  Lidocaine P.O →↑metabolites
                       ↓
                  CNS toxicity
Poorly Extracted Drug
Diazepam 100%
Digitoxin    90%
Theophylline 96%

Shunting of blood past the liver will cause little
  change in availability.
       ER = Clliver
                 Q

       Clliver =   Q   x   Ci – C O
                           Ci
Drug clearance
Clearance (CL) is the measure of
   removal of drug from body
• expressed as:
  volume of plasma from which all drug
  is removed in a given time e.g.

   ml/min or L/h
• It is estimated as:
  Blood Clearance (CLb),
  Plasma Clearance (CLP),
  Unbound drug Clearance (CLu)
Drug clearance
It is similar to creatinine/urea clearance.
Creatinine Clereance = UV
                              P
Renal Clearance=
  Conc. in urine x rate of urine formation
           Conc. in plasma
Clearance of a drug =
     Rate of elimination of all routes
     Conc. in any body fluid
or CL = Rate of elimination or Dose
                   C               AUC
Organ clearance
CLorgan = Rate of eliminationORGAN
                     CP
Total systemic clearance:
CLsyst = CLrenal + CLliver + CLother


CLorgan = Blood flow x Extraction Ratio
         =       Q         x      ER
         =       Q         x     Ci – CO
                                       C
DRUG CLEARANCE
Factors related to clearance
A.   First Order Elimination
B.   Capacity Limited Elimination
C.   Flow Dependent
D.   Plasma Protein binding
A. First Order Elimination
    Rate of elimination = Cp x CL organ

For most drugs elimination is not saturable &
is directly proportional to concentration

Can be calculated by AUC

                           CL: Dose
                               AUC
CL= Dose/AUC
B. Capacity Limited Elimination
Zero Order Elimination, Saturable, Nonlinear,
Dose dependent or Michaelis’ Menten Elimination
                           Vmax x C
 Rate of Elimination= --------------
                         Km + C
The concentration will keep on rising as
long as dosing continues & steady state
can not be reached.
Ethanol, Phenytoin & Aspirin
AUC can not be used to calculate clearance
C. Flow Dependent

 Elimination depends on the rate of delivery
 of drug to the organ of elimination

CLorgan = Blood flow x Extraction Ratio
       =     Q       x    ER
       =     Q       x   Ci – CO
                            Ci
D. Plasma Protien binding
            & Blood Cell partitioning
• Plasma Protein binding may be important for
  extensively bound drugs:
    Phenytoin 89%,
    Salicylic acid 85% (Aspirin 49%)
 When the amount of unbound drug in plasma
  increases the rate of elimination will increase.
 When plasma proteins are lower than normal
  then total drug concentration will be lower but
  unbound concentration will not be affected.
Factors affecting protein binding
• Albumen Concentration In many diseases
  albumin level is low, resulting in lower total
  drug concentration (phenytoin, salicylate &
  disopyramide)
• Alpha1-acid glycoprotein concentration It is
  ↑ed in acute inflammatory disease ↑ing
  total plasma conc. of propranolol, lidocain
  & quinidine.
• Capacity limited protein binding
  salicylates & prednisolone
Renal clearance of
       Benzyl Penicillin
Filtration 10 %
Tubular secretion 90 %
Glomerular filtration rate = 127ml/min
Renal clearance = 480 ml/min
Estimation of GFR
The most commonly used formula is the
"4-variable MDRD," (Modification of Diet in Renal
Disease Study Group) which estimates GFR using
Four variables: serum creatinine, age, race, and
               gender
Cockcroft-Gault formula
 There is age related decline in renal
  functions
 There is decline of muscle mass with age
 Therefore reduction in production of
  creatinine
Creatinine clearance (mL/min)=
           140-age x wt in kg
     72 x serum creatinine in mg/dL
                       (x 0.85 for females)
Thank You

More Related Content

What's hot

What's hot (20)

Sympathomimetics- pharmacology
Sympathomimetics- pharmacologySympathomimetics- pharmacology
Sympathomimetics- pharmacology
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
Anticholinesterases
AnticholinesterasesAnticholinesterases
Anticholinesterases
 
Nsaids
NsaidsNsaids
Nsaids
 
Receptor - Pharmacology
Receptor - PharmacologyReceptor - Pharmacology
Receptor - Pharmacology
 
Fibrinolytics & antiplatelets
Fibrinolytics & antiplateletsFibrinolytics & antiplatelets
Fibrinolytics & antiplatelets
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 
NSAIDS rem rai
NSAIDS rem raiNSAIDS rem rai
NSAIDS rem rai
 
Renal clearance
Renal clearanceRenal clearance
Renal clearance
 
Barbiturate & Morphine poisoning
Barbiturate & Morphine poisoningBarbiturate & Morphine poisoning
Barbiturate & Morphine poisoning
 
Proton pump inhibitors
Proton pump inhibitorsProton pump inhibitors
Proton pump inhibitors
 
Drug Antagonism
Drug AntagonismDrug Antagonism
Drug Antagonism
 
Asthma
AsthmaAsthma
Asthma
 
Lectures 12 Plasma Half Life and steady state concentrtiion
Lectures 12 Plasma Half Life and steady state concentrtiionLectures 12 Plasma Half Life and steady state concentrtiion
Lectures 12 Plasma Half Life and steady state concentrtiion
 
Clinical pharmacokinetics part 1 dr jayesh vaghela
Clinical pharmacokinetics part 1 dr jayesh vaghelaClinical pharmacokinetics part 1 dr jayesh vaghela
Clinical pharmacokinetics part 1 dr jayesh vaghela
 
Pharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugsPharmacokinetics: Excretion of drugs
Pharmacokinetics: Excretion of drugs
 
Cholinergic system and drugs
Cholinergic system and drugsCholinergic system and drugs
Cholinergic system and drugs
 
Effect of drugs on frog’s heart
Effect of drugs on frog’s heart Effect of drugs on frog’s heart
Effect of drugs on frog’s heart
 
Drugs for heart failure
Drugs for heart failureDrugs for heart failure
Drugs for heart failure
 
Cholinergic transmission and drugs
Cholinergic transmission and  drugsCholinergic transmission and  drugs
Cholinergic transmission and drugs
 

Similar to Clinical pharmaco kinetics 1 bioavailability, 1st pass, renal clearance 2011

Bioavailability studies lecture7
Bioavailability studies lecture7Bioavailability studies lecture7
Bioavailability studies lecture7
homebwoi
 
Pharmacokinetics Overview
Pharmacokinetics OverviewPharmacokinetics Overview
Pharmacokinetics Overview
Amad Islam
 

Similar to Clinical pharmaco kinetics 1 bioavailability, 1st pass, renal clearance 2011 (20)

Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Kinetika En 2002
Kinetika En 2002Kinetika En 2002
Kinetika En 2002
 
Bioavailability studies lecture7
Bioavailability studies lecture7Bioavailability studies lecture7
Bioavailability studies lecture7
 
Aaditya- calculation of pk parameters
Aaditya- calculation of pk parametersAaditya- calculation of pk parameters
Aaditya- calculation of pk parameters
 
Excretion and kinetic of eliminatoin.. dr. kiran 15th feb 2021
Excretion and kinetic of eliminatoin.. dr. kiran 15th feb 2021Excretion and kinetic of eliminatoin.. dr. kiran 15th feb 2021
Excretion and kinetic of eliminatoin.. dr. kiran 15th feb 2021
 
Renal clearance
Renal clearanceRenal clearance
Renal clearance
 
Pharmacokinetics
Pharmacokinetics Pharmacokinetics
Pharmacokinetics
 
Drug Clearance
Drug ClearanceDrug Clearance
Drug Clearance
 
Practice 4(1)_General Pharmacology.ppt
Practice 4(1)_General Pharmacology.pptPractice 4(1)_General Pharmacology.ppt
Practice 4(1)_General Pharmacology.ppt
 
Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics ppt
 
Pharmacokinetics ppt
Pharmacokinetics pptPharmacokinetics ppt
Pharmacokinetics ppt
 
Pharmacokinetics Overview
Pharmacokinetics OverviewPharmacokinetics Overview
Pharmacokinetics Overview
 
Pocket Guide: Pharmacokinetics Made Easy - sample
Pocket Guide: Pharmacokinetics Made Easy - sample Pocket Guide: Pharmacokinetics Made Easy - sample
Pocket Guide: Pharmacokinetics Made Easy - sample
 
Bioavailabity.pharmacology lecture.pp tx
Bioavailabity.pharmacology lecture.pp txBioavailabity.pharmacology lecture.pp tx
Bioavailabity.pharmacology lecture.pp tx
 
Kinetics of ADME by Mukesh Jaiswal
Kinetics of ADME by Mukesh JaiswalKinetics of ADME by Mukesh Jaiswal
Kinetics of ADME by Mukesh Jaiswal
 
Excretion and kinetic of eliminatoin.. dr. kiran December 2021
Excretion and kinetic of eliminatoin.. dr. kiran  December 2021Excretion and kinetic of eliminatoin.. dr. kiran  December 2021
Excretion and kinetic of eliminatoin.. dr. kiran December 2021
 
Expt. 13 Calculation of pharmacokinetic parameters from a given data
Expt. 13 Calculation of pharmacokinetic parameters from a given dataExpt. 13 Calculation of pharmacokinetic parameters from a given data
Expt. 13 Calculation of pharmacokinetic parameters from a given data
 
Bioavailability and bioequivalane studies
Bioavailability and bioequivalane studiesBioavailability and bioequivalane studies
Bioavailability and bioequivalane studies
 
Estimation of pharmacokinetic parameters
Estimation of pharmacokinetic parametersEstimation of pharmacokinetic parameters
Estimation of pharmacokinetic parameters
 
BioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdfBioavailabilityandBioequivalence.pdf
BioavailabilityandBioequivalence.pdf
 

More from Muhammad Saim (20)

Mc
McMc
Mc
 
Kub guide without tos
Kub guide without tosKub guide without tos
Kub guide without tos
 
Asthma copd
Asthma copdAsthma copd
Asthma copd
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Chronic stable angina
Chronic stable anginaChronic stable angina
Chronic stable angina
 
Clinical cases for ccf
Clinical cases for ccfClinical cases for ccf
Clinical cases for ccf
 
Dr fahad anti arrythmic drugs
Dr fahad anti arrythmic drugsDr fahad anti arrythmic drugs
Dr fahad anti arrythmic drugs
 
Hypertension
HypertensionHypertension
Hypertension
 
Clinical cases for ccf
Clinical cases for ccfClinical cases for ccf
Clinical cases for ccf
 
2003 cvs shifa permeation through biological membranes
2003 cvs shifa permeation through biological membranes2003 cvs shifa permeation through biological membranes
2003 cvs shifa permeation through biological membranes
 
Arrythmia
ArrythmiaArrythmia
Arrythmia
 
Cvs
CvsCvs
Cvs
 
Retina and visual tract
Retina and visual tractRetina and visual tract
Retina and visual tract
 
Orbit
OrbitOrbit
Orbit
 
Lids,lacrimation
Lids,lacrimationLids,lacrimation
Lids,lacrimation
 
Cranial nerves iii, iv,vi
Cranial nerves iii, iv,viCranial nerves iii, iv,vi
Cranial nerves iii, iv,vi
 
Eye layers 1
Eye layers 1Eye layers 1
Eye layers 1
 
Refractive errors
Refractive errorsRefractive errors
Refractive errors
 
Limbic system
Limbic systemLimbic system
Limbic system
 

Recently uploaded

Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
negromaestrong
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 

Recently uploaded (20)

Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Asian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptxAsian American Pacific Islander Month DDSD 2024.pptx
Asian American Pacific Islander Month DDSD 2024.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Magic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptxMagic bus Group work1and 2 (Team 3).pptx
Magic bus Group work1and 2 (Team 3).pptx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 

Clinical pharmaco kinetics 1 bioavailability, 1st pass, renal clearance 2011

  • 1. Clinical Pharmacokinetics-1 Prof. Dr. Talat Ahmed
  • 2. THEORIES OF DRUG DISTRIBUTION AND ELIMINATION
  • 3. THEORIES OF DRUG DISTRIBUTION AND ELIMINATION 1. Single compartment a) b) theory. central peripheral 2. Two compartment blood muscle theory CSF skin 3. Multiple lung fat compartment liver bones theory. Kidney F, AUC, CL, Vd, t12, Css
  • 5. Bioavailability (F) is the fraction of unchanged drug reaching the systemic circulation. I/V administration = 1F (100% bioavailability)  AUC= area under curve: It is a measure of the extent of bioavailability given by a particular route.  F= AUC after IM or oral dose AUC after I/V dose
  • 7. FACTORS AFFECYING BIOAVAILABILITY 1. EXTENT OF ABSORPTION (= f) 2. RATE OF ABSORPTION 3. FIRST PASS ELIMINATION
  • 8. Factors Affecting Bioavailability 1. EXTENT OF ABSORPTION (= f) : Bioavailability is the function of absorption=f digoxin, 70% intestinal microflora atenolol, 56% too hydrophilic acyclovir 23% too lipophilic Grape fruit juice:↑ drug absorption 1)P-glycoprotein inhibition 2)↓wall metabolism
  • 9. 2. RATE OF ABSORPTION: it affects rate of availability, determined by: a) Drug formulation b) Amount of given drug. c) Site of Administration.
  • 11. a) Drug formulation • Disintegration & dissolution time Depends: 1.Compression pressure 2.Moisture Content 3.Nature of additives: excipients - starch, lubricants, disintegrents 4.Particle size 5.Polymorphism of molecule or ions 6.pH
  • 12. Bioequivalence Pharmaceutical Equivalent/Generic 1. Same active ingredient 2. Same strength /concentration 3. Same Dosage Form 4. Same route of Admn. Bioequivalent When rate & extent of bioavailability of active ingredient in two products is similar. Therapeutic Equivalence When two products produce same response in same dosage (e.g. aconitine hazard)
  • 13. b) Amount of given drug • FIRST ORDER ABSORPTION: rate of absorption is proportional to the amount of drug in gut. • ZERO ORDER ABSORPTION: when rate of absorption is not proportionate to the amount of drug in the gut. (when full dose is not absorbed from GI fluids)
  • 14. c)Site of Administration Oral Topical Transdermal Intramuscular Subcutaneous Sublingual Rectal Inhalation
  • 15. 3. FIRST PASS ELIMINATION: orally administered drug ↓ gut wall ↓ portal blood ↓ liver bile systemic circulation
  • 16. The First Pass Effect and Extraction Ratio Effect of first pass elimination on bioavailability is expressed as extraction ratio = ER If a drug is completely absorbed from the gut its systemic bioavailability F = l (100 %) If it passes through liver, it will be decreased by hepatic extraction F = l – ER
  • 17. Extent Of Absorption = f (predicts systemic bioavailability of drug) F = f x (1- ER) For morphine f =1 ER = 0.67 F = 1 x (1- 0.67) = 33% ( observed value 24%)
  • 18. Highly Extracted Drugs Therapeutic blood concentration can be reached by high oral dose Lidocaine 20 % Verapamil 20% Propranolol 26% Lidocaine P.O →↑metabolites ↓ CNS toxicity
  • 19. Poorly Extracted Drug Diazepam 100% Digitoxin 90% Theophylline 96% Shunting of blood past the liver will cause little change in availability. ER = Clliver Q Clliver = Q x Ci – C O Ci
  • 21. Clearance (CL) is the measure of removal of drug from body • expressed as: volume of plasma from which all drug is removed in a given time e.g. ml/min or L/h • It is estimated as: Blood Clearance (CLb), Plasma Clearance (CLP), Unbound drug Clearance (CLu)
  • 22. Drug clearance It is similar to creatinine/urea clearance. Creatinine Clereance = UV P Renal Clearance= Conc. in urine x rate of urine formation Conc. in plasma Clearance of a drug = Rate of elimination of all routes Conc. in any body fluid or CL = Rate of elimination or Dose C AUC
  • 23. Organ clearance CLorgan = Rate of eliminationORGAN CP Total systemic clearance: CLsyst = CLrenal + CLliver + CLother CLorgan = Blood flow x Extraction Ratio = Q x ER = Q x Ci – CO C
  • 25. Factors related to clearance A. First Order Elimination B. Capacity Limited Elimination C. Flow Dependent D. Plasma Protein binding
  • 26. A. First Order Elimination Rate of elimination = Cp x CL organ For most drugs elimination is not saturable & is directly proportional to concentration Can be calculated by AUC CL: Dose AUC
  • 28. B. Capacity Limited Elimination Zero Order Elimination, Saturable, Nonlinear, Dose dependent or Michaelis’ Menten Elimination Vmax x C Rate of Elimination= -------------- Km + C The concentration will keep on rising as long as dosing continues & steady state can not be reached. Ethanol, Phenytoin & Aspirin AUC can not be used to calculate clearance
  • 29. C. Flow Dependent Elimination depends on the rate of delivery of drug to the organ of elimination CLorgan = Blood flow x Extraction Ratio = Q x ER = Q x Ci – CO Ci
  • 30. D. Plasma Protien binding & Blood Cell partitioning • Plasma Protein binding may be important for extensively bound drugs: Phenytoin 89%, Salicylic acid 85% (Aspirin 49%)  When the amount of unbound drug in plasma increases the rate of elimination will increase.  When plasma proteins are lower than normal then total drug concentration will be lower but unbound concentration will not be affected.
  • 31. Factors affecting protein binding • Albumen Concentration In many diseases albumin level is low, resulting in lower total drug concentration (phenytoin, salicylate & disopyramide) • Alpha1-acid glycoprotein concentration It is ↑ed in acute inflammatory disease ↑ing total plasma conc. of propranolol, lidocain & quinidine. • Capacity limited protein binding salicylates & prednisolone
  • 32. Renal clearance of Benzyl Penicillin Filtration 10 % Tubular secretion 90 % Glomerular filtration rate = 127ml/min Renal clearance = 480 ml/min Estimation of GFR The most commonly used formula is the "4-variable MDRD," (Modification of Diet in Renal Disease Study Group) which estimates GFR using Four variables: serum creatinine, age, race, and gender
  • 33. Cockcroft-Gault formula  There is age related decline in renal functions  There is decline of muscle mass with age  Therefore reduction in production of creatinine Creatinine clearance (mL/min)= 140-age x wt in kg 72 x serum creatinine in mg/dL (x 0.85 for females)